Clinical Trial Details
EORTC-30993
Back to Clinical Trials Database
A randomized phase II trial of sequential chemo-immunotherapy versus immunotherapy alone in carcinoma in situ of the urinary bladder.
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 07-Jun-2001 Date Step1 close: 21-Feb-2005 |
| Data management at EORTC | Yes |
| Design |
Phase 2 Randomized open label |
| Targeted Sample size | EORTC Groups: 90 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/NCT00023842 |
| NCT number | NCT00023842 |
